Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XIAP | P98170 | 1/20 | 0.53 |
| ▸ | ELANE | P08246 | 4/20 | 0.42 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.41 |
| ▸ | NTSR2 | O95665 | 4/20 | 0.40 |
| ▸ | NTSR1 | P30989 | 4/20 | 0.40 |
| ▸ | SORT1 | Q99523 | 4/20 | 0.40 |
| ▸ | REN | P00797 | 2/20 | 0.40 |
| ▸ | DPP4 | P27487 | 1/20 | 0.40 |
| ▸ | FAP | Q12884 | 1/20 | 0.40 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.40 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.40 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.40 |
| ▸ | GRB2 | P62993 | 1/20 | 0.40 |
| ▸ | ACE | P12821 | 2/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23135343 | 1.00 | XIAP (0.53) | XIAPELANECALCRLNTSR2NTSR1 | |
| SCHEMBL31031582 | 0.89 | XIAP (0.48) | XIAPELANECALCRLSLC6A2 | |
| SCHEMBL21312919 | 0.89 | XIAP (0.47) | XIAPELANENTSR2NTSR1SORT1 | |
| SCHEMBL29641668 | 0.88 | XIAP (0.58) | XIAPELANERENDPP4FAP | |
| SCHEMBL29641778 | 0.88 | XIAP (0.47) | XIAPELANECALCRLNTSR2NTSR1 | |
| SCHEMBL30185042 | 0.86 | XIAP (0.48) | XIAPELANECALCRLNTSR2NTSR1 | |
| SCHEMBL29641583 | 0.85 | XIAP (0.59) | XIAPELANERENDPP4DPP8 | |
| SCHEMBL2408415 | 0.85 | OPRM1 (0.48) | XIAPRENDPP4FAPDPP8 | |
| SCHEMBL30844308 | 0.84 | CMA1 (0.51) | XIAPELANECALCRLRENDPP4 | |
| SCHEMBL30872267 | 0.83 | CAPN1 (0.46) | XIAPCALCRLOPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210087138-A1 | AMINOMETHYL-FUNCTIONALIZED DENATONIUM DERIVATIVES, THEIR PREPARATION AND USE | JULIUS-MAXIMILIANS-UNIVERSITAET WUERZBURG (DE) | 2021-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210087138-A1 | AMINOMETHYL-FUNCTIONALIZED DENATONIUM DERIVATIVES, THEIR PREPARATION AND USE | F10, F11, HRH4 | XIAP 4267/4885ELANE 1065/4885CALCRL 384/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.